Form D · Pharmaceuticals
HAUS BIOCEUTICALS INC
Oklahoma City, OK · CIK 0001541491
Offering snapshot reported Feb 14, 2012 · SEC filing
- Reported sold
- $150K Offering amount: $350K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Feb 1, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2012 | Initial | $150,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-173427
Source: Form D, filed Feb 14, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Philip Alex | Director |
| Michael Centola | Director, Executive |
| Adam J. Payne | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
755 Research Parkway Suite 460
Oklahoma City, OK, 73104
Oklahoma City, OK, 73104